TRU-SENTIMENT · DeltaNeutral
MRK Trading Analysis - 10/23/2026 02:05 PM — TRU-SENTIMENT
Options chain · Stock chart · Baseline chart
MRK (Merck & Co. Inc.) at $147.35. True Sentiment Balanced, delta 40-60 call 45% / put 55%, call $881,445 vs put $1,079,823. RSI 56.5.
- Symbol
- MRK
- Price
- $147.35
- Article bias (separate from True Sentiment)
- neutral
- Conviction
- low
- Published
- 2026-10-23 14:05:00 ET
- Author
- DeltaNeutral staff
TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)
True Sentiment Analysis (Delta 40-60 Options)From the True Sentiment options file (Delta 40-60 only):
Call Dollar Volume: $881,445 (44.9%) Put Dollar Volume: $1,079,823 (55.1%) Total: $1,961,268
- Sentiment labeled "Balanced" with put notional edge of ~$198K.
- Call contracts 1,683 vs put 1,955; call trades 35 vs put 32 — similar trade count, more put contracts.
- Filter ratio 5.1% (67 of 1,314 options analyzed) shows limited pure directional conviction.
- Read: near-term expectations are non-directional; no strong bullish or bearish flow confirmation.
Key Statistics: MRK
Fundamental Snapshot
Valuation
| P/E (trailing) | 116.80 |
| EPS (trailing 12 mo) | $1.27 |
| Market cap | $365.81B |
| Shares outstanding | 2,467.2M |
Dividend
| Dividend yield | 2.29% |
| Annual dividend | $3.40 |
| Ex-dividend date | 2026-09-15 |
Risk & range
| Beta | -0.02 |
| 52-week low | $82.01 |
| 52-week high | $156.92 |
| Historical volatility | 26.4% |
Ownership & trading
| Institutional ownership | 55.2% |
| Average daily volume | 9.2M sh |
Reported figures; no analyst estimates.
📈 Analysis
News Headlines & Context
Recent general-knowledge headlines and context for Merck & Co (MRK) that may frame the current trading environment:
- MRK recently completed ex-dividend date on 2026-09-15 with a declared dividend rate of $3.40 (yield 2.29%), a routine shareholder event with no major surprise.
- Pipeline headlines around Keytruda expansion and HPV vaccine demand have circulated in prior quarters; no blockbuster catalyst confirmed in provided data.
- Broad pharma sector has faced pricing-policy and patent-cliff discussions, which can introduce headline volatility for large caps like MRK.
- No earnings date is embedded in the data; fiscal year end is listed as 2025-12-01, suggesting next full-year reporting is not imminent in the window shown.
- Context: The news backdrop is calm relative to the sharp 2026-10-22 intraday range ($144.07–$154.02), where price reversed hard off highs into the close.
Fundamental Analysis
Based strictly on the embedded FUNDAMENTALS data for MRK:
- Trailing P/E is 116.80 with trailing EPS of $1.27 — a rich multiple versus typical large-cap pharma peers in the mid-teens to low-30s P/E.
- PEG ratio, forward P/E, forward EPS, profit margins, ROE, debt/equity, and free cash flow are all null — unavailable in the data, preventing margin-quality assessment.
- Market cap is $365.81B with 2.47B shares outstanding; institutional ownership is 55.21%.
- Dividend yield 2.29% (rate $3.40) provides income context but no growth signal in the data.
- Beta is -0.02, indicating historically low/negative correlation to broad market moves in the dataset.
- 52-week range: $82.01 low to $156.92 high; current price $148.27 sits in the upper-middle of that range.
- Analyst consensus and target mean price are null — no street target context provided.
- Fundamentals show a high valuation with missing margin data, which diverges from the neutral-to-mildly-positive technical picture and balanced options sentiment.
Current Market Position
Current price per indicators is $148.27 (2026-10-22 close). Recent daily action shows a gap-up open at $151.05 on 2026-10-22, a session high of $154.02, then a collapse to low $144.07 and close $148.27 on volume of 15.63M (well above 20-day avg of 5.90M).
Minute bars for 2026-10-21 to 2026-10-22 show opening strength to ~$149.84 on 10-21, then on 10-22 a fade from $149.49 at 15:35 to $147.35 by 15:55 with volume spikes to 543,130 in the final bar — clear late-session distribution.
Technical Analysis
Technical Indicators
- Price $148.27 is above SMA 5 ($147.23), SMA 20 ($145.47), and SMA 50 ($146.50) — short-term alignment is mildly bullish but compressed.
- RSI 14 at 56.52 shows neutral-to-soft momentum, no overbought condition.
- MACD line 0.81 > signal 0.64, histogram +0.16 — mild positive momentum, no bearish divergence in data.
- Bollinger middle $145.47, upper $151.26, lower $139.69; price inside upper half, not at band extreme.
- 30-day range high $154.02, low $138.80; price at $148.27 is ~64% up the range.
True Sentiment Analysis (Delta 40-60 Options)
From the True Sentiment options file (Delta 40-60 only):
Call Dollar Volume: $881,445 (44.9%) Put Dollar Volume: $1,079,823 (55.1%) Total: $1,961,268
- Sentiment labeled "Balanced" with put notional edge of ~$198K.
- Call contracts 1,683 vs put 1,955; call trades 35 vs put 32 — similar trade count, more put contracts.
- Filter ratio 5.1% (67 of 1,314 options analyzed) shows limited pure directional conviction.
- Read: near-term expectations are non-directional; no strong bullish or bearish flow confirmation.
Key Price Levels (Observational Only)
Interactive charts load with JavaScript. This text is the crawlable summary.